News › Industry News

Venus Concept Announces FDA 510(k) Clearance for Venus Viva MD

July 2, 2020

Venus Concept Inc., a global medical aesthetic technology leader, has announced that it has received FDA 510(k) clearance to market and sell Venus Viva MD, a non-invasive device intended to be used by aesthetic-related physicians or dermatologists. It expands the company’s skin rejuvenation offerings beyond the Venus Viva and Venus Versa, which were introduced to the medical aesthetics market in 2015 and 2016, respectively.
Read more at Globe Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • The Beauty Health Company (SKIN) Rebrands to SkinHealth Systems
    • Amazon Launches GLP-1 Weight Loss Program with One Medical
    • Botox Cosmetic’s “The Confidence Collective” to Empower 250 Women Entrepreneurs
    • Medical Spa Show 2027 Call for Presentations Now Open
    • FDA Warning Letter to Texas Medical Spa Signals Increased Compliance Enforcement